Adjuvant chemotherapy in the treatment of high grade gliomas

Cancer Treatment Reviews

Volumn 31, Issue 2, 2005, Pages 79-89

  Lonardi, Sara ^a   Tosoni, Alicia ^a   Brandes, Alba A ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Adjuvant; Brain tumours; Chemotherapy; Clinical trials; Prognosis; Radiotherapy; Review; Survival

Indexed keywords

1 (2 CHLOROETHYL) 3 (2,6 DIOXO 3 PIPERIDYL) 1 NITROSOUREA; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CYTARABINE; DACARBAZINE; ERLOTINIB; GEFITINIB; HYDROXYUREA; IMATINIB; LOMUSTINE; METHYLPREDNISOLONE; MISONIDAZOLE; MITOLACTOL; MONOCLONAL ANTIBODY; NIMUSTINE; NITROSOUREA; PROCARBAZINE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; SEMUSTINE; STREPTOZOCIN; TEMOZOLOMIDE; TENIPOSIDE; TIPIFARNIB; VINCRISTINE;

AGE DISTRIBUTION; ARTICLE; BIODEGRADABLE IMPLANT; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; FATIGUE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL DISEASE; GLIOBLASTOMA; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; LIVER TOXICITY; META ANALYSIS; PERIPHERAL NEUROPATHY; PROGNOSIS; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; GLIOMA; HUMANS; PATIENT SELECTION; PROGNOSIS;

EID: 17444402489     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2004.12.005     Document Type: Article

References (58)

1. A. Jemal T. Murray A. Samuels et al. Cancer Statistic 2003 CA Cancer J Clin 53 2003 5-26
2. C.B. Scott C. Scarantino R. Urtasun et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06 Int J Radiat Oncol Biol Phys 40 1998 51-55
3. D.P. Byar S.B. Green T.A. Strike Prognostic factors for malignant glioma In: M.D. Walker editor. Oncology of the nervous system 1983 Martinus Nijhoff Boston 379-395
4. D.R. Macdonald New frontiers in the treatment of malignant glioma Semin Oncol 30 6 Suppl 19 2003 72-76
5. K.A. Jaekle H.J. Eyre J.J. Towsend et al. Correlation of tumour O6 methilguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosurea: A Southwest Oncology Group study J Clin Oncol 16 1998 3310-3315
6. W.J. Curran Jr. C.B. Scott J. Horton et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 1993 9704-9710
7. Medical Research Council Brain Tumour Working Party: Prognostic factors for high-grade malignant gliomas: Development of a prognostic index. J Neurooncol 1990;9:47-55
8. C.H. Chang J. Horton D. Schoenfeld et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas Cancer 52 1983 997-1007
9. J.R. Simpson J. Horton C. Scott et al. Influence of location and extent resection on survival of patients with glioblastoma multiforme: Results of three consecutive RTOG clinical trials Int J Radiat Oncol Biol Phys 26 1993 239-244
10. J.R. Wood S.B. Green W.R. Shapiro The prognostic importance of tumour size in malignant gliomas: A computed tomographic scan study by the Brain Tumour Cooperative Group J Clin Oncol 6 1988 338-343
11. M.D. Walker E. Alexander Jr. W.E. Hult et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas J Neurosurg 49 1978 333-343
12. K. Kristiansen S. Hagen T. Kollevold et al. Combined modality therapy of operated astrocytomas grade III and IV: Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time Cancer 47 1981 649-652
13. L.M. deAngelis Brain tumours New Engl J Med 344 2 2001 114-123
14. M.D. Walker S.B. Green D.P. Byar et al. Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery N Engl J Med 303 1980 1323-1329
15. S.B. Green D.P. Byar M.D. Walker et al. Comparisons of carmustine, procarbazine and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma Cancer Treat Rep 67 1983 121-132
16. V.A. Levin P. Silver I. Hannigan et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report Int J Radiat Oncol Biol Phys 18 1990 321-324
17. Medical Research Council Brain Tumour Working Party: Randomised trial of procarbazine, lomustine and vincristine in the adjuvant treatment of high grade astrocytoma. J Clin Oncol 2001;19:509-518
18. L.M. deAngelis P.C. Burger S.B. Green et al. Malignant glioma: Who benefits from adjuvant chemotherapy? Ann Neurol 44 1998 691-695
19. M.D. Prados C. Scott W.J. Curranjr et al. Procarbazine, Lomustine, and Vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy J Clin Oncol 17 1999 3389-3395
20. H.A. Fine K.B.G. Dear J.S. Loeffier et al. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585-2597
21. L.A. Stewart et al. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Glioma Meta-Analysis Trialists (GM1) Group Lancet 359 2002 1011-1018
22. M. Weller B. Muller R. Koch et al. Neuro-Oncology Working Group of the German Cancer Society: Neuro-Oncology Working Group 01 Trial of nimustine plus tenitoposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first line treatment of malignant glioma J Clin Oncol 21 2003 3276-3284
23. R. Stupp W.P. Mason M.J. Van Den Bent et al. Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain and RT Groups and NCIC Clinical Trials Group Proc Am Soc Clin Oncol 22 2004 2 [abstract 2]
24. H.B. Newton Molecular neuroncology and development of targeted therapeutic strategies for brain tumours Expert Rev Anticancer Ther 3 2003 595-614
25. E. Raymond A. Brandes A. Van Oosterom et al. Multicentre phase II study with imatnib mesylate in patikents with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study Proc Am Soc Clin Oncol 22 2004 107 [abstract 1501]
26. W.K. Yung R.e. Albright J. Olson et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J cancer 83 2000 588-593
27. A. Katz C.H. Barrios R. Abramoff et al. Imatinib (STI571) is active in patients with high grade gliomas progressing on standard therapy Proc Am Soc Clin Oncol 22 2004 117 [abstract 1542]
28. J.N. Rich D.A. Reardon T. Peery et al. Phase II trial of gefitinib in recurrent glioblastoma J Clin Oncol 22 2004 133-142
29. J.J. Raizer L.E. Abrey P. Wen et al. a phase II trial of erlotinib (OSI-774) in patients with recurrent malignant gliomas not on EIAEDs Proc Am Soc Clin Oncol 22 2004 107 [abstract 1502]
30. T. Cloughesy J. Kuhun P. Wen et al. Phase II trial of R115777 (Zarnestra) in patients with recurrent not taking enzyme inducing anti-epileptic drugs (EIAED): A North American Brain Tumour Consortium (NABTC) report Proc Am Soc Clin Oncol 21:80a 2003 [abstr 317]
31. T. Tomita Interstitial chemotherapy for brain tumours: Review J Neurooncol 10 1991 57-74
32. H. Brem S. Piantadosi P.C. Burger et al. lacebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumour Treatment Group Lancet 345 1995 1008-1012
33. S. Valtonen U. Timonen P. Toivanen et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study Neurosurgery 41 1997 44-48
34. M. Westphal D.C. Hilt E. Bortey et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology 5 2003 79-88
35. G. Cairncross D. Macdonald S. Ludwin et al. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 12 1994 2013-2021
36. G. Bonadonna P. Valagussa Dose-response effect of adjuvant chemotherapy in breast cancer N Engl J Med 304 1981 10-15
37. W.K.A. Yung R.E. Albright et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse Br J Cancer 83 2000 588-593
38. A.A. Brandes M. Ermani U. Basso et al. Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: A phase II study Oncology 63 2002 38-41
39. A.A. Brandes F. Vastola U. Basso et al. A prospective study on glioblastoma in the elderly Cancer 97 2003 657-662
40. D. Osoba M. Brada W.K.A. Yung et al. Health related quality of life(HRQOL) in patients treated with temozolomide (TMZ) versus procarbazine (PCB) for recurrent GBM J Clin Oncol 18 2000 1481-1491
41. R. Stupp P.Y. Dietrich S. Ostermann et al. Kraljevic Promising survival for patients with newly diagnosed glioblastoma multiforme (GBM) treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 2002 1375-1382
42. J. Dinnes C. Cave S. Huang et al. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma Br J Cancer 86 2002 501-505
43. B. Weir P. Band R. Urtasun et al. Radiotherapy and CCNU in the treatment of high-grade supratentorial astrocytomas J Neurosurg 45 1976 129-134
44. C.L. Solero S. Monfardini C. Brambilla et al. Controlled study with BCNU versus CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme Cancer Clin Trials 2 1979 43-48
45. EORTC Brain Tumour Group: Evaluation of CCNU, VM-26 plus CCNU and procarbazine in supratentorial brain gliomas. J Neurosurg 1981;55:27-31
46. H.J. Eyre J.M. Quagliana J.R. Eltringham et al. Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery J Neuro-Oncol 1 1983 171-177
47. R.P. Dinapoli L.O. Brown R.M. Arusell et al. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high grade glioma J Clin Oncol 11 1993 1316
48. D. Áfra B. Kocsis J. Dobay et al. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas J Neurosurg 59 1983 106-110
49. R. Hatlevoll K. Lindegaard S. Hagen et al. Combined modality treatment of operated astrocytomas grade 3 and 4: A prospective and randomised study of misonidazole and radiotherapy with two different radiation schedules and subsequent CCNU chemotherapy Cancer 56 1985 41-47
50. D.F. Nelson M. Diener-West A.S. Weinstein et al. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG study Int J Radiat Oncol Biol Phys 12 1986 1793
51. K. Takakura H. Abe R. Tanaka et al. Effects of ACNU and radiotherapy on malignant glioma J Neurosurg 64 1986 53-57
52. T. Trojanowski J. Peszynski K. Turowski et al. Post-operative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas J Neuro-Oncol 6 1988 285-291
53. M. Deutsch S.B. Green T.A. Strike et al. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma Int J Radiat Oncol Biol Phys 16 1989 1389
54. W.R. Shapiro S.E. Green P.C. Burger et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumour Cooperative Group trial 8001 J Neurosurg 71 1989 1
55. W.R. Shapiro S.B. Green P.C. Burger et al. A randomized comparison of intra- arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant gliomas J Neurosurg 76 1992 772
56. J. Hildebrand T. Sahmoud F. Mignolet et al. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas Neurology 44 1994 1479-1483
57. T.E. Elliot R.P. Dinapoli J.R. O'Fallon et al. Randomized trial of radiation therapy (RT) plus dibromodulcitol (DBD) versus RT plus BCNU in high-grade astrocytoma J Neuro-Oncol 33 1997 219-250
58. J.C. Buckner P.J. Schomberg W.L. McGinnis et al. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma Cancer 92 2001 420-433